AGA Center for Gut Microbiome Research & Education
Major programs
Industry partners
For industries working in the microbiome space, the center can work with you to evaluate your product and help bring it to market.
AGA's Microbiome Center in the news
Dr. Phillip Tarr, chair of the AGA Center for Gut Microbiome Research & Education Scientific Advisory Board, comments on the significance of FDA’s approval of Rebyota to treat recurrent CDI.
Geoffrey Preidis, MD, PhD, speaks to CNN about AGA’s new clinical practice guidelines on probiotics for the management of GI diseases.
Alexander Khoruts, MD, provides perspective on AGA’s new clinical practice guidelines on probiotics.
Rob Knight, PhD, provides a new understanding of the way microbial populations shift with cancer could open a completely new therapeutic avenue.
Scientific Advisory Board
The mission of the AGA Center for Gut Microbiome Research and Education is to advance research and education on the gut microbiome with the goal of improving human health. To provide guidance on gut microbiome-related issues, AGA has convened a scientific advisory board comprised of world leaders in computational biology and metagenomics, microbiome animal models, microbiology translational research, nutrition, and pertinent regulatory and policy issues.
Phillip I. Tarr, MD
Chair
Purna Kashyap, MBBS, AGAF
Chair elect
Thaddeus Stappenbeck, MD, PhD, AGAF
Governing Board Liaison
Theresa Alenghat, VMD, PhD
Muyiwa Awoniyi, MD, PhD
Suzanne Devkota, PhD
Ex-officio
Sara Di Rienzi, PhD
Ari Grinspan, MD, AGAF
Aaron Hecht, MD, PhD
Trainee
Diane Hoffman, JD, MS
Lori Holtz, MD, MSPH
Rohit Loomba, MD
Long Nguyen, MD, MS
Mark Pimentel, MD
Ryan Ranallo, PhD
